000 01436 a2200385 4500
005 20250516231456.0
264 0 _c20150519
008 201505s 0 0 eng d
022 _a1432-0738
024 7 _a10.1007/s00204-014-1338-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLim, Jamie L
245 0 0 _aAntioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
_h[electronic resource]
260 _bArchives of toxicology
_cOct 2014
300 _a1773-86 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xmetabolism
650 0 4 _aBrain
_xdrug effects
650 0 4 _aDisease Models, Animal
650 0 4 _aHumans
650 0 4 _aMicroglia
_xdrug effects
650 0 4 _aMitochondria
_xdrug effects
650 0 4 _aNF-E2-Related Factor 2
_xmetabolism
650 0 4 _aNeurodegenerative Diseases
_xdrug therapy
650 0 4 _aOxidative Stress
_xdrug effects
650 0 4 _aReactive Oxygen Species
_xmetabolism
700 1 _aWilhelmus, Micha M M
700 1 _ade Vries, Helga E
700 1 _aDrukarch, Benjamin
700 1 _aHoozemans, Jeroen J M
700 1 _avan Horssen, Jack
773 0 _tArchives of toxicology
_gvol. 88
_gno. 10
_gp. 1773-86
856 4 0 _uhttps://doi.org/10.1007/s00204-014-1338-z
_zAvailable from publisher's website
999 _c24137495
_d24137495